Universe Pharmaceuticals ...

NASDAQ: UPC · Real-Time Price · USD
3.54
-0.02 (-0.56%)
At close: Aug 15, 2025, 11:58 AM

Universe Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-8.73M -6.58M -7.91M 11.32M
Depreciation & Amortization
485.73K 508.79K 533.95K 446.88K
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-2.14M 273.14K 10.02M -10.82M
Other Non-Cash Items
186.19K -45.74K 5.97K -468.17K
Deferred Income Tax
606.7K 1.57M -542.38K -668.34K
Change in Working Capital
-2.06M 5.67M 6.6M -12.69M
Operating Cash Flow
-9.51M 1.12M -1.31M -2.06M
Capital Expenditures
-363.09K -44.17K -93.7K -13.53M
Cash Acquisitions
n/a n/a -3.81M 26.62M
Purchase of Investments
n/a n/a n/a -15.33M
Sales Maturities Of Investments
n/a n/a n/a 1.8M
Other Investing Acitivies
-115.49K n/a 523.00 -26.62M
Investing Cash Flow
-361.29K -44.17K -3.91M -27.06M
Debt Repayment
8.95M -1.39M 3.32M 624.35K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a -2.79M
Financial Cash Flow
33.95M -1.39M 3.32M 26.58M
Net Cash Flow
24.21M -426.21K -2.37M -1.98M
Free Cash Flow
-9.87M 1.08M -1.41M -15.59M